Hud-forskning
Kobberpeptider og forbindelser til dermal forskning. Nedenfor er den publicerede litteratur for hver forbindelse inden for dette område — 123 studier i alt, 62 af dem publiceret siden 2023, alle linket til deres kildepost.
- HudKun præklinisk
AHK-Cu
AHK-Cu (L-alanyl-L-histidyl-L-lysine copper(II), INCI-tilstødende til den kosmetiske ingrediens Tripeptide-3) er en strukturel analog af GHK-Cu, hvori glycin er erstattet af alanin. Det direkte publicerede evidensgrundlag er meget lille: en enkelt ex vivo- og cellekulturstudie af humane hårsække og dermale papillaceller er den primære dermatologiske kilde, suppleret af en topisk leveringsstudie af Tripeptide-3 for ansigtstalg og af arbejde med et C-vitamin-konjugeret AHK-derivat i en ikke-kutan model. De fleste påstande fremsat for AHK-Cu er ekstrapoleret fra den bredere kobber-tripeptid-litteratur snarere end fra AHK-specifikke data.
- Studier
- 10
- Siden 2023
- 6
- Nyeste
- 2026
- HudTidlig klinisk
GHK-Cu
GHK (glycyl-L-histidyl-L-lysine) is an endogenous human plasma tripeptide that binds copper(II) with high affinity. In cell culture it increases fibroblast collagen and glycosaminoglycan synthesis at picomolar to nanomolar concentrations, and gene-expression work reports broad modulation of extracellular-matrix, antioxidant and inflammatory programmes. Human data are limited: most published work is in vitro or in animal models, and the small number of controlled human trials of topical GHK-Cu have produced mixed results, including two randomised trials that found no advantage over comparator or placebo.
- Studier
- 21
- Siden 2023
- 12
- Nyeste
- 2026
- HudKlinisk
Healthy Hair, Skin & Nails Blend
Biotin (vitamin B7) is an essential cofactor for five carboxylases, and frank biotin deficiency causes alopecia and dermatitis that resolve with repletion. In people without a deficiency, however, the evidence that supplemental biotin improves hair, skin or nail outcomes is weak: systematic and narrative reviews consistently find only a handful of small, biased or negative studies. High-dose biotin is also a recognised cause of clinically significant interference in streptavidin-biotin immunoassays, producing falsely raised or lowered results for thyroid, cardiac, hormone and other analytes. Other B vitamins have their own dermatological evidence base, with nicotinamide the best studied, showing benefit for keratinocyte-cancer chemoprevention in immunocompetent high-risk patients but no benefit in organ-transplant recipients.
- Studier
- 38
- Siden 2023
- 20
- Nyeste
- 2026
- HudKun præklinisk
KLOW Blend
KLOW is a marketed combination of four peptides: BPC-157, TB-500 (a fragment-based thymosin beta-4 analogue), GHK-Cu and KPV. A systematic search of PubMed and Europe PMC returned no published study of this four-peptide blend in any model, and no pharmacokinetic, efficacy or safety data exist for the combination. The available literature is component-level: BPC-157 rests almost entirely on rodent work from a small number of laboratories with only two very small uncontrolled human pilot studies; thymosin beta-4 has two randomised phase 2 wound trials; KPV is supported by in vitro and animal anti-inflammatory work; and GHK-Cu is covered separately in this dataset. Only one published study examines any two of the components together.
- Studier
- 18
- Siden 2023
- 11
- Nyeste
- 2026
- HudGodkendt lægemiddel
Melanotan 2
Melanotan II and afamelanotide are synthetic analogues of alpha-melanocyte-stimulating hormone that act at melanocortin receptors to increase eumelanin synthesis. Afamelanotide (a selective, largely MC1R-directed analogue) is an approved medicine for erythropoietic protoporphyria supported by randomised placebo-controlled trials and post-authorisation safety cohorts, and has been trialled with narrowband UV-B in vitiligo. Melanotan II is a non-selective, unlicensed peptide sold illegally for tanning; it has never been through a completed efficacy or safety programme; beyond a 1996 pilot study and two small placebo-controlled crossover trials in erectile dysfunction (1998 and 2000), its published human literature consists mainly of adverse-event case reports, including eruptive and dysplastic naevi, melanoma and mucosal melanoma, priapism, renal infarction and systemic reactions.
- Studier
- 36
- Siden 2023
- 13
- Nyeste
- 2026
Senest publiceret forskning
A framework for the safety evaluation of peptides in cosmetics.
Current Research in Toxicology · review af historisk kosmetisk peptid-sikkerhedsevaluering plus et foreslået seks-værktøj bioinformatisk framework
PubMed · 41953401Copper(II)-Tripeptide Complexes as Potential Skin Healing Agents: Synthesis, Characterization, and Wound Repair Ability.
ChemMedChem · syntese og karakterisering af copper(II)-tripeptid-komplekser med sårheling-assays
PubMed · 42047624Overview of Short Peptides for Hair Loss.
Biomedicines · narrativ review af korte peptider undersøgt for hårtab
PubMed · 42072405A Torilis japonica Extract-GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis.
Antioxidants (Basel) · TNF-alpha/IFN-gamma-stimulated HaCaT keratinocyte model of atopic dermatitis
PubMed · 42510549Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed-Culture Ferment Extract by Tripeptide GHK-Cu.
Skin Research and Technology · in vitro (LPS-stimulated macrophages), ex vivo skin, plus human application testing
PubMed · 42573538GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap.
Pharmaceutics · structured systematic evidence-mapping review of PubMed, Europe PMC, ClinicalTrials.gov and EU/US/ICH regulatory sources to August 2026; no quantitative pooling
PubMed · 42797253Multi-Target Restoration of Dermal Elastic Fibers Through Elastin Upregulation, Elastase Suppression, and Scaffold Reinforcement.
Current Issues in Molecular Biology · human dermal fibroblast cultures; multi-ingredient comparison
PubMed · 42193036Peptide-enriched hydrogel formulation for sensitive and damaged skin: from design to application testing.
Scientific Reports · formulation development plus in vitro human skin cell assays and dermatological testing in human participants
PubMed · 42032121
Kun til forskningsformål. Ikke til humant forbrug, diagnose, behandling eller forebyggelse af nogen tilstand. Intet på denne side er medicinsk rådgivning.